COVID-19: Impact on Neurological Health
The COVID-19 virus is known to cause a multitude of symptoms that affect different parts of the body, including the brain. Recent studies have revealed that approximately 80 percent of individuals hospitalized with COVID-19 experienced some form of neurological symptoms. These symptoms range from mild to severe and include the loss of taste and smell, brain damage, difficulty remembering words, coma, and stroke.
Furthermore, research has indicated that individuals with pre-existing neurological conditions, such as nerve diseases, dementia, and chronic migraines, are at a higher risk of experiencing neurological symptoms in conjunction with COVID-19. The correlation between these underlying conditions and the virus underscores the importance of monitoring and managing neurological health during the ongoing pandemic.
Implications of Infection on the Blood-Brain Barrier
The blood-brain barrier, a protective layer comprised of tightly interconnected cells, separates the brain’s blood vessels from the brain itself. This crucial barrier plays a vital role in maintaining balance and preventing the entry of harmful substances, including toxins, diseases, and pathogens. However, systemic infection and inflammation have the potential to disrupt this barrier, leading to increased permeability.
Researchers have observed that the heightened permeability of the blood-brain barrier may explain the impact of various infections on the brain. This discovery has sparked interest in exploring the therapeutic potential of this permeability for future treatments of numerous conditions.